RNAimmune accelerates R&D into mRNA vaccine, drug discovery

RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...

April 23, 2021 | Friday | News
Pureos Bioventures closes first fund with committed capital of $205 M

Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (Pureos) with a committed...

April 22, 2021 | Thursday | News
CAR-T therapy leads Singapore medical tourism within APAC

The inherent heterogeneity of diseases such as cancer is driving the field of personalized (precision) therapies. Within...

April 12, 2021 | Monday | Analysis
Hitachi uses digital technology for creation of next-generation biopharmaceuticals

Hitachi, Ltd. and Axcelead, Inc. have announced that they have agreed on a comprehensive collaborative partnership to de...

April 7, 2021 | Wednesday | News
Shanghai Genchem announces global collaboration with I-Mab on Bispecific antibodies

Shanghai Genechem Co., Ltd., a discovery company dedicated to novel drug target discovery and development of novel thera...

April 6, 2021 | Tuesday | News
Peptone to scale its AI-driven protein engineering system PeOS in Iceland

Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, ...

April 5, 2021 | Monday | News
Industry accelerates R&D of innovative antibody drugs

A global leading biotech company GenScript Biotech Corporation has announced that the Company has entered into a strateg...

March 26, 2021 | Friday | News
PerkinElmer expands computing capabilities for biological drug discovery

PerkinElmer, Inc., has announced that its Signals ™ computing platform for documentation, workflow ...

March 22, 2021 | Monday | News
Fujitsu, NCC to create new services for clinical trials, drug development in Japan

Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...

March 18, 2021 | Thursday | News
Eisai aims for novel drug discovery for neurodegenerative disorders

German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...

March 17, 2021 | Wednesday | News
QBiotics joins TDM Growth Partners to accelerate drug development timelines

QBiotics Group Limited, a Brisbane (Australia) life sciences company developing novel anticancer and wound healing pharm...

March 16, 2021 | Tuesday | News
Boehringer Ingelheim to develop innovative Peptides to treat Obesity

Boehringer Ingelheim and Gubra on March, 1st 2021 announced a new research and licensing agreement focused on ...

March 1, 2021 | Monday | News
HitGen, UPPTHERA collaborate for drug discovery research

Chinese firm HitGen has announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to ...

March 2, 2021 | Tuesday | News
Insilico Medicine discovers industry first preclinical drug candidate using AI

China based Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug disco...

February 25, 2021 | Thursday | News
China's Suntrap discovers LeSoleil to fight COVID-19 and future epidemics

AI-assisted computing has greatly improved the efficiency of new drug research and development. China's Suntrap Life Tec...

February 15, 2021 | Monday | News
The Next-generation antimalarial treatment designed to tackle the drug-resistance challenge

Since the previous century, Tropical and subtropical regions have been grappling under the parasitic...

February 9, 2021 | Tuesday | Opinion
Korea approves first anti-COVID-19 monoclonal antibody treatment

Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...

February 8, 2021 | Monday | News
India's Biocon Biologics to offer Oncology Biosimilars in over 30 countries

Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...

February 5, 2021 | Friday | News